AICDA and B-cell chronic lymphocytic leukemia: Because ibrutinib has been shown to rapidly inhibit CLL B cell proliferation in vitro (187, 188) and in vivo in mouse (188) and man (189), we tested if it would affect the size of the recently divided, proliferative fraction and thereby block AID expression (190).